Literature DB >> 11783088

[Expression of VEGF, bFGF and ER in endometrial carcinoma].

X Bai1, R Mi.   

Abstract

OBJECTIVE: To investigate the expression of VEGF, bFGF and ER in endometrial carcinoma and its relation to the clinico-pathological manifestations and prognosis.
METHODS: A total of 66 specimens of endometrial carcinoma and 19 normal endometrium was studied by immunohistological technique with polyclonal antibodies against VEGF and bFGF, and monoclonal antibody against ER.
RESULTS: Positive expression rate of VEGF in endometrial carcinoma was 80.3%. Expression of VEGF was positively correlated with tumor grade (P < 0.01). Expression of VEGF was positively correlated with that of bFGF (P < 0.05). Negative correlation was observed between ER expression and tumor grade (P < 0.05). Prognosis of patients with negative ER expression was poor. No correlation existed between ER expression and that of VEGF and bFGF.
CONCLUSION: Expression of VEGF and bFGF may indicate that both of them contribute in the angiogenesis of endometrial carcinoma. Expression of ER has prognostic significance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11783088

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  1 in total

1.  Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics.

Authors:  Agnieszka Wanda Piastowska-Ciesielska; Elżbieta Płuciennik; Katarzyna Wójcik-Krowiranda; Andrzej Bieńkiewicz; Andrzej Bednarek; Tomasz Ochędalski
Journal:  Tumour Biol       Date:  2011-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.